Podcast In The Headlines: A good week for NIH, a bad week for Vinay Prasad August 06, 2025Vol.51 No.30
Podcast In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial. July 30, 2025Vol.51 No.29
Conversation with The Cancer Letter Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out July 25, 2025Vol.51 No.29By Sara Willa Ernst, Jacquelyn Cobb and Paul Goldberg
Cancer Policy FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts July 25, 2025Vol.51 No.29By Jacquelyn Cobb
Clinical Roundup Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests July 18, 2025Vol.51 No.28
Cancer Policy Supreme Court lifts lower-court freeze on RIFs July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Funding Opportunities NCI, SITC immunotherapy fellowship calls for applications July 11, 2025Vol.51 No.27
FreeGuest Editorial As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures July 03, 2025Vol.51 No.26By George J. Weiner and Elizabeth M. Jaffee
In Brief RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients June 27, 2025Vol.51 No.25
PodcastThe Directors The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woesDirectors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” June 13, 2025Vol.51 No.23By Paul Goldberg
